المؤلفون: Aygen, Bilgehan, Demirtürk, Neşe, Yıldız, Orhan, Çelen, Mustafa Kemal, Çelik, İlhami, Barut, Şener, Ural, Önur, Batırel, Ayşe, Mıstık, Reşit, Şi̇mşek, Funda, Asan, Ali, Ersöz, Gülden Munis, Türker, Nesrin Akbaş, Bilgin, Hüseyin, Kınıklı, Sami, Karakeçili, Faruk, Zararsız, Gökmen, Günal, Özgür, Akhan, Sıla Cetin, Tulek, N., İnan, Dilara, Çaǧatay, Arif Atahan, Gürbüz, Yunus, Şener, Alper, Çelikbaş, Aysel Kocagül, Çetinkaya, Rıza Aytaç, Kadanalı, Ayten, Hakyemez, İsmail Necati, Kuruüzüm, Ziya, Özel, Selcan Arslan, Korkmaz, Pınar Yagiz, Tuna, Nazan, Saltoǧlu, Neşe, Tarakçı, Hüseyin, Uysal, Burcu, Karagöz, Ergenekon, Koçulu, Safiye, Ayaz, Celal, Güzel, Deniz Kamalak, Türkoğlu, Emine, Demir, Nazlım Aktuğ, Şimşek, Sümeyra, Kantürk, Arzu, Akça, Mustafa Özgür, Evik, Güliz, Örmen, Bahar Kopraman, Sili, Uluhan, Hatipoǧlu, Çiǧdem Ataman, Binay, Umut Devrim, Kılıç, Sırrı, Arslan, Kader, Yenilmez, Ercan, Çomoǧlu, Şenol, Koç, Meliha Meriç, Gökgöz, Altan, Dursun, Zehra Beştepe, Sümer, Şua, Heper, Yasemin, Yíldírmak, Taner T., Öztürk, Sinan, Güğül, Tuğba Demirel, Yüce, Zeynep Türe

مصطلحات موضوعية: Chronic hepatitis C, Dasabuvir, HCV genotypes 1 and 4, Ombitasvir, Paritaprevir, Real-world effectiveness

وصف الملف: application/pdf

Relation: Turkish Journal of Gastroenterology; Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı; Aygen, B., Demirtürk, N., Yıldız, O., Çelen, M. K., Çelik, İ., Barut, Ş. ve diğerleri. (2020). Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience. Turkish Journal of Gastroenterology, 31(4), 305-317.; https://www.turkjgastroenterol.org/en/real-world-efficacy-safety-and-clinical-outcomes-of-ombitasvir-paritaprevir-ritonavir-dasabuvir-ribavirin-combination-therapy-in-patients-with-hepatitis-c-virus-genotype-1-or-4-infection-the-turkey-experience-experience-136659; https://hdl.handle.net/11468/7219; 31; 305; 317; WOS:000535263200004; 2-s2.0-85084787334; https://search.trdizin.gov.tr/yayin/detay/419482; Q3; Q4

الاتاحة: https://hdl.handle.net/11468/7219
https://www.turkjgastroenterol.org/en/real-world-efficacy-safety-and-clinical-outcomes-of-ombitasvir-paritaprevir-ritonavir-dasabuvir-ribavirin-combination-therapy-in-patients-with-hepatitis-c-virus-genotype-1-or-4-infection-the-turkey-experience-experience-136659
https://search.trdizin.gov.tr/yayin/detay/419482
https://doi.org/10.5152/TJG.2020.19197

المؤلفون: Özsüt Halit H, Yildirmak Taner T, Çalangu Semra S, Öncü Serkan S, Çagatay Atahan A, Eraksoy Haluk H

المصدر: BMC Infectious Diseases, Vol 1, Iss 1, p 22 (2001)

مصطلحات موضوعية: Infectious and parasitic diseases, RC109-216

Relation: http://www.biomedcentral.com/1471-2334/1/22; https://doaj.org/toc/1471-2334; https://doaj.org/article/31fde81a622f4a3e9bfcacca664ee650

الاتاحة: https://doi.org/10.1186/1471-2334-1-22
https://doaj.org/article/31fde81a622f4a3e9bfcacca664ee650

المؤلفون: Çagatay, Atahan A, Öncü, Serkan S, Çalangu, Semra S, Yildirmak, Taner T, Özsüt, Halit H, Eraksoy, Haluk H

Relation: http://www.biomedcentral.com/1471-2334/1/22

الاتاحة: http://www.biomedcentral.com/1471-2334/1/22